Mycolates of Mycobacterium tuberculosis modulate the flow of cholesterol for bacillary proliferation in murine macrophages

J Lipid Res. 2017 Apr;58(4):709-718. doi: 10.1194/jlr.M073171. Epub 2017 Feb 13.

Abstract

The differentiation of macrophages into lipid-filled foam cells is a hallmark of the lung granuloma that forms in patients with active tuberculosis (TB). Mycolic acids (MAs), the abundant lipid virulence factors in the cell wall of Mycobacterium tuberculosis (Mtb), can induce this foam phenotype possibly as a way to perturb host cell lipid homeostasis to support the infection. It is not exactly clear how MAs allow differentiation of foam cells during Mtb infection. Here we investigated how chemically synthetic MAs, each with a defined stereochemistry similar to natural Mtb-associated mycolates, influence cell foamy phenotype and mycobacterial proliferation in murine host macrophages. Using light and laser-scanning-confocal microscopy, we assessed the influence of MA structure first on the induction of granuloma cell types, second on intracellular cholesterol accumulation, and finally on mycobacterial growth. While methoxy-MAs (mMAs) effected multi-vacuolar giant cell formation, keto-MAs (kMAs) induced abundant intracellular lipid droplets that were packed with esterified cholesterol. Macrophages from mice treated with kMA were permissive to mycobacterial growth, whereas cells from mMA treatment were not. This suggests a separate yet key involvement of oxygenated MAs in manipulating host cell lipid homeostasis to establish the state of TB.

Keywords: confocal microscopy; foam cell; infection; lipid droplets; liver X receptor; mycolic acid; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cholesterol / metabolism*
  • Foam Cells / drug effects
  • Foam Cells / metabolism
  • Granuloma / drug therapy*
  • Granuloma / metabolism
  • Granuloma / pathology
  • Humans
  • Lipid Droplets / drug effects
  • Lipid Droplets / metabolism
  • Lung / metabolism
  • Lung / pathology
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Mice
  • Mycobacterium tuberculosis / chemistry
  • Mycobacterium tuberculosis / pathogenicity
  • Mycolic Acids / administration & dosage*
  • Mycolic Acids / chemical synthesis
  • Tuberculosis / drug therapy*
  • Tuberculosis / metabolism
  • Tuberculosis / microbiology
  • Tuberculosis / pathology

Substances

  • Mycolic Acids
  • Cholesterol